Prevalence of ocular manifestations in systemic sclerosis patients

Archives of Medical Science

Volumn 9, Issue 6, 2013, Pages 1107-1113

  Waszczykowska, Arleta ^a   Goś, Roman ^a   Waszczykowska, Elzbieta ^a   Dziankowska Bartkowiak, Bozena ^a   Jurowski, Piotr ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Eye complications; Retinal changes; Scleroderma

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRY EYE; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; REFRACTION ERROR; SUBCAPSULAR CATARACT; SYSTEMIC SCLEROSIS; VISION; VISUAL ACUITY; VISUAL DISORDER; VISUAL SYSTEM EXAMINATION;

EID: 84892430086     PISSN: 17341922     EISSN: 18969151     Source Type: Journal    
DOI: 10.5114/aoms.2013.39217     Document Type: Article

References (33)

1. Dziankowska-Bartkowiak B, Gerlicz-Kowalczuk Z, Waszczy-kowska E. Angiogenin and SDF-1alpha serum concen-tration in patients with systemic sclerosis in relation to clinical status. Arch Med Sci 2011; 1: 92-6.
2. Nadashkevich O, Davis P, Fritzler MJ. A proposal of criteria for the classification of systemic sclerosis. Med Sci Monit 2004; 10: 615-21.
3. Clements PJ, Roth MD, Elashoff R, et al.; Scleroderma Lung Study Group. Scleroderma lung study (SLS): Differences in the presentation and course of patients with limited versus diffuse systemic sclerosis. Ann Rheum Dis 2007; 66: 1641-7.
4. Plastiras SC, Karadimitrakis SP, Kampolis C, Moutsopoulos HM, Tzelepis GE. Determinants of pulmonary arterial hypertension in scleroderma. Semin Arthritis Rheum 2007; 36: 393-6.
5. Chmiel K, Krela-Kamierczak I, ykowska-Szuber L, et al. Association between dermatological diseases and pathological changes in the gastrointestinal tract. Postep Derm Alergol 2011; 28: 506-13.
6. Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007; 66: 940-4.
7. Albert DM, Jakobiec FA. Principles and practice of ophthalmology. W.B.Saunders Company, Philadelphia 2000; 5: 4589-95.
8. Horie K, Nishi M, Sawa M, Mochizuki M. A case of peripheral corneal ulcer accompanied by progressive systemic sclerosis. Nippon Ganka Gakkai Zasshi 1992; 96: 922-9.
9. Zulian F, Vallongo C, Woo P, et al.; Juvenile Scleroderma Working Group of the Pediatric Rheumatology European Society (PRES). Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum 2005; 52: 2873-81.
10. Sii F, Lee GA, Sanfilippo P, Stephensen DC. Pellucid marginal degeneration and scleroderma. Clin Exp Optom 2004; 87: 180-4.
11. Allanore Y, Parc C, Monnet D, Brezin A, Kahan A. Increased prevalence of ocular glaucomatous abnormalities in systemic sclerosis. Ann Rheum Dis 2004; 63: 1276-8.
12. Serup L, Serup J, Hagdrup HK. Increased central cornea thickness in systemic sclerosis. Acta Ophthalmol 1984; 62: 69-74.
13. Serup J, Serup L. Increased central cornea thickness in localized scleroderma (morphoea). Metab Pediatr Syst Ophthalmol 1985; 8: 11-4.
14. Egerer I, Fanta D. Changes in the ocular muscles in pro-gressive scleroderma. Klin Monatsbl Augenheilkd 1976; 168: 216-20.
15. Boschi A, Snyers B, Lambert M. Bilateral optic neuropathy associated with the crest variant of scleroderma. Eur J Ophthalmol 1993; 3: 219-22.
16. Ushiyama O, Ushiyama K, Yamada T, et al. Retinal findings in systemic sclerosis: A comparison with nailfold capillaro-scopic patterns. Ann Rheum Dis 2003; 62: 204-7.
17. Das CP, Prabhakar S, Lal V, Kharbanda PS. Scleroderma, stroke, optic neuropathy: A rare association. Neurol India 2002; 50: 504-7.
18. Airo' P, Scarsi M, Rossi M, Mondini M. Onset and enhancement of systemic sclerosis after treatments for multiple sclerosis. Rheumatol Int 2008; 28: 703-7.
19. Mabon M, Whitcher JP, Anderson R. Bilateral scleral pit associated with systemic sclerosis. Am J Ophthalmol 1999; 128: 521-2.
20. Sivaraj RR, Durrani OM, Denniston AK, Murray PI, Gor-don C. Ocular manifestations of systemic lupus erythe-matosus. Rheumatology 2007; 46: 1757-62.
21. Shahneh FZ, Babalo Z, Baradaran B, Sepehr KS. Insights into Behçet's disease. Postep Derm Alergol 2012; 29: 461-6.
22. Pastuszka M, Kaszuba A. Status of combination drugs with betamethasone dipropionate and salicylic acid in the treatment of skin diseases. Postep Derm Alergol 2012; 29: 196-204.
23. Daczak-Pazdrowska A. Place of methotrexate in the treatment of psoriasis in the era of biologic agents. Postep Derm Alergol 2012; 29: 182-8.
24. Chan AY, Liu DT. Increased prevalence of ocular glaucomatous abnormalities in systemic sclerosis. Ann Rheum Dis 2005; 64: 341-2.
25. Peter S, Dietrich H, Wick G. Investigations for retinopathy in an avian model for systemic sclerosis. Exp Eye Res 2004; 79: 85-92.
26. Kraus A, Guerra-Bautista G, Espinoza G, et al. Defects of the retinal pigment epithelium in scleroderma. Br J Rheumatol 1991; 30: 112-4.
27. Egerer I, Fanta D, Freyler H. Fundus changes in scle-roderma. Klin Monatsbl Augenheilkd 1975; 167: 571-6.
28. Serup L, Serup J, Hagdrup H. Fundus fluorescein angio-graphy in generalized scleroderma. Ophthalmic Res 1987; 19: 303-8.
29. Milenkovic S, Petrovic L, Risimic D, et al. Choroidal sclerosis in localized scleroderma (morphea en plaque). Ophthalmic Res 2008; 40: 101-4.
30. Saari KM, Rudenberg HA, Laitinen O. Bilateral central retinal vein occlusion in a patient with scleroderma. Ophthalmologica 1981; 182: 7-12.
31. Berndt K, Hoffmann A. Closure of the central artery of the retina in progressive scleroderma. Klin Monatsbl Augenheilkd 1977; 171: 597-600.
32. Peter S, Dietrich H, Wick G. Investigations for retinopathy in an avian model for systemic sclerosis. Exp Eye Res 2004; 79: 85-92.
33. Venkatesh P, Bhaskar VM, Keshavamurthy R, Garg S. Proliferative vascular retinopathy in polymyositis and dermatomyositis with scleroderma (overlap syndrome). Ocul Immunol Inflamm 2007; 15: 45-9.